Merck & Co.’s hangover from the withdrawal of its $2.5 billion a year arthritis drug Vioxx has lifted, according to Chief Executive Richard Clark, and the drugmaker is starting to flex its muscles again. 

Cardinal Health CEO R. Kerry Clark likens the efforts to lure him from Procter & Gamble into the top spot at the drug wholesaler as something of a mating dance with the company’s former chief executive.

 Bristol-Myers Squibb interim CEO James Cornelius weighs his Hawaiian vacation against taking over at the troubled drugmaker. He tells the Reuters Health Summit his name is not among the list of potential candidates for the permanent CEO job but he remains committed to staying on until a new chief is named. 

   How did HealthSouth Corp. employees greet the news that their former boss, Richard Scrushy, had been convicted of bribery? With an aquatic frolic in the once forbidden fountain.

HealthSouth Corp. Chief Executive Jay Grinney’s taste in office furnishings favor the common man approach. He found the lavish excesses of his predecessor Richard Scrushy to be more than a little over the top for a health care company.